chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Limited range of movement; Right wrist is swollen; pain in her hand and wrist/ Right hand hurting; pain in her hand and wrist/ Right wrist hurting; Right hand is quite swollen; This is a spontaneous report from a contactable consumer or other non hcp.  A 31-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number ER8737) dose 1 via an unspecified route of administration, administered in Arm Left on 02Apr2021 11:30 (age at vaccination 31) as dose 1, Single for covid-19 immunisation. Medical history was not reported and concomitant drug was Antibiotic eye cream. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine.  Caller got the first dose of the Covid Vaccine on 02Apr2021, this past Friday. She got it in her left arm. On 3Apr2021, the next day her right hand and wrist started hurting. She thought it was unrelated, but it got worse. Her hand is quite swollen. She has no other symptoms. She has never had any issues with arthritis or anything like that. She went to Urgent Care. X-rays didn't show anything. They suggested it was a potential vaccine reaction. It hasn't gotten worse or better. Another doctor said it could be a vaccine thing and to reach out to Pfizer and see if we have heard about anything like this happening before or have any tips on what to do about it. Antibiotic eye cream took it for a few days a week or 2 weeks before she got the vaccine. She was not currently taking it, she finished it. The patient had Right hand and wrist felt like a sprain at first. It was not severe the first day, but towards the evening it got worse. The pain has decreased a bit. She has been taking Tylenol. On 4Apr2021, Her hand and wrist are swollen, and she has a limited range of movement. She can't bend it. The pain started out not too bad. On 5Apr2021, that Sunday it was bad enough to go to Urgent Care. She has been in a brace and since then it has gotten better. If she moves it, it is worse. The swelling started Saturday, but she didn't notice it until Sunday. She can move it a little bit, it was pretty swollen. She thinks the 4th character in the lot number is a 7 or a 1, but she is pretty sure it is a 7. She hates needles, and having a reaction was something she was scared of. This is the worst thing that could have happened. She will still get the second dose. She is not 100 percent sure, she is not a doctor, but it is suspicious that it happened right after getting the vaccine and she had never had any problems.  The patient underwent lab tests and procedures which included x-ray: unknown result as Nothing found in report on an unknown date. The outcome of event right wrist is swollen was not recovered, pain in her hand and wrist/ right hand hurting was unknown, pain in her hand and wrist/ right wrist hurting was unknown , right hand is quite swollen was not recovered , limited range of was not recovered.
POSSIBLE MULTIPLE POTENTIAL ADMINISTRATION ERROR; MULTIPLE FREEZING TEMPERATURE EXCURSIONS POSSIBLY MORE THAN 20 UNPUNCTURED VIALS; This spontaneous report received from a patient concerned multiple patients.  No past medical history or concurrent conditions were reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 041A21A expiry: 19-SEP-2021) dose, start therapy date were not reported for prophylactic vaccination. No concomitant medications were reported. On 29-APR-2021, the subject experienced possible multiple potential administration error. On 29-APR-2021, the subject experienced multiple freezing temperature excursions possibly more than 20 unpunctured vials. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the possible multiple potential administration error and multiple freezing temperature excursions possibly more than 20 unpunctured vials was not reported. This report was non-serious. This case, from the same reporter is linked to 20210807547.
Immediate rx to arm. Scratchy throat. Second day symptoms  increased, cough, etc. Third say even worse. Stomach distress. Family dr started antibiotic, cough medicine, inhaler. Admitted to the hospital with exacerbation of asthma, rx to flu vaccine, respiratory distress. Hospital x 4 days. IV steroids, antibiotics, resp. therapy. Long story short off work FOUR months. Attempted to return to the Operating Room in Feb 2014 against Pulmonologist Recommendation because out of sick time. Worked several weeks. Relapse. Been off since. Immune system decrease. Continuous SOB. Decreased lung function. Latest Pulmonary fx test lungs 44 %. LOTS of medical records. Now being followed by facility.  Seeing Pulmonologists Endocrinologist. Steroids for almost 90 days. Unable now to do normal activities.
pain and swelling all over my body; pain and swelling all over my body; spinning out of control with the worst dizziness; tingling in my fingers; lump in my throat; burning sensation and cramping that felt like explosions were going off in my joints in my knees, elbows, ankles and under my rib cage; burning sensation and cramping that felt like explosions were going off in my joints in my knees, elbows, ankles and under my rib cage; tingling in my fingers and my tongue; mild allergic reaction; This is a spontaneous report from a contactable consumer (patient). A 51-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) at the age of 51 years old, via an unspecified route of administration, administered in Arm Right on 22Apr2021 17:30 (Batch/Lot Number: EWO153(7/21)) as DOSE 1, SINGLE for COVID-19 immunization in a Pharmacy or Drug Store. Medical history included allergy to many chemicals and have suffered from mercury poisoning, low thyroid and fibromaialgia (over 10 years ago) from an unknown date. There were no concomitant medications. The patient was not pregnant at time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Immediately after receiving the injection on 22Apr2021, at 07:00 PM the patient stated, "I had some tingling in my fingers and my tongue followed by a little bit of a lump in my throat, assumingly a mild allergic reaction but about 2 hours later, I reached down to pet my dog and started spinning out of control with the worst dizziness I have ever had in my life. Called the hospital but they did not have any answers so I just sat still and slept sitting up. The dizziness resided over the next couple days but on about the third day I had pain and swelling all over my body that lasted at least a month followed by another episode of dizziness. I had a burning sensation and cramping that felt like explosions were going off in my joints in my knees, elbows, ankles and under my rib cage. I did not get the second shot and am still only partially vaccinated". The events resulted in doctor or other healthcare professional office/clinic visit. No treatment given for the events. The patient has not been COVID-9 tested since the vaccination. The patient was not diagnosed with COVID-19 prior to vaccination. The outcome of events was recovered on unspecified date.  Follow-up attempts are completed. No further information is expected.
the patient received unauthorized vaccine/ patient was not age 12 at the time that the vaccine was administered
10/5 Received Vaccine 10/6 reported localized reddness, generalized fatigue, chills, body aches and sweating.  10/07 Increased reddness at site, upper right arm painful and difficult to move 10/10 increased inflammation to 4 inches in diameter.
Redness, heat, swelling at site that continued to worsen over the next 5 days. Patient states that the swelling, redness, and heat at the site that spread from her "shoulder bone to elbow." She was advised to use cool compresses and take diphenhydramine and to seek medical treatment if anything changes.
Describe the adverse event(s), treatment, and outcome(s), if any: (symptoms, signs, time course, etc.) Event: Pediatric Pfizer Vaccine Lot Number FK5127, was improperly stored in an Immunizations Freezer that maintained a temperature between -15 Celsius and -24 Celsius. Per the Manufacture?s guidelines the vaccine must be stored in a Refrigerator maintaining temperature of 2-8 Degrees Celsius or an Ultra-Low Cold Freezer maintaining temperature of -90C or lower. The patient received the vaccine that was improperly stored.  Treatment: Not required, patient did not report any adverse reactions to the Vaccine.  Outcome: Patient?s guardian notified and offered to restart the Pediatric Pfizer Covid Vaccine series again stored at the proper temperature.  Signs, Symptoms course, etc. None reported by the patient?s guardian
continued Dizziness; headache; itching; unable to concentrate or focus; This is a spontaneous report from a contactable consumer, the patient. A 68-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the left arm on 06Apr2021(at the age of 68-years-old) as a single dose for COVID-19 immunisation. Medical history included type 1 diabetes mellitus. The patient had unspecified allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received medications within two weeks of vaccination. Since the vaccination, the patient had not been tested for COVID-19. On 06Apr2021 at 20:00, the patient experienced continued dizziness, headache, itching, unable to concentrate or focus, it's been a week since vaccine and symptoms are better but still exist. It was unknown whether any therapeutic measures were taken as a result of the event. The event resulted in doctor or other healthcare professional office/clinic visit.  The clinical outcome of the events were continued dizziness, headache, itching, unable to concentrate or focus was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Patient received 0.5ml instead of the normal 0.3ml dose.  Two days post injection, he had not had any adverse reactions.
Information has been received from a 60 year old nurse with "controlled blood pressure", gastrooesophageal reflux disease (reported as "GERD or NUD"), "bad knees", "bungions", dry eyes, cough variant asthma and sulfonamide allergy who on 10-OCT-2007 was vaccinated with a dose of ZOSTAVAX 0.5 ml, IM "for shingles recurrence prevention". Vaccines received the same day included influenza virus vaccine (unspecified) (manufacturer unknown). Concomitant therapy included PREVACID, RESTASIS, RESTORIL, SONATAm NORVASC, "Solutab". The nurse reported that she was given ZOSTAVAX in one arm and influenza virus vaccine (unspecified) in the other arm. She reported that they both hurt but that the ZOSTAVAX hurt more than the flu shot. The pain lasted about 5 days to one week (date of recovery reported as 10-OCT-2007). The patient did not seek medical attention. There was no product quality complaint. No further information is available.
Contracted COVID; This spontaneous case was reported by an other health care professional and describes the occurrence of COVID-19 (Contracted COVID) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (Contracted COVID). At the time of the report, COVID-19 (Contracted COVID) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported. No treatment medication was reported. The patient was scheduled for second Moderna vaccine on 10-Feb-2021.  This is a regulatory authority case concerning  a patient of unknown age and gender, with no relevant medical history, who experienced the unexpected non-serious events of Covid-19. The events occurred approximately on an unknown day after the first dose of mRNA-1273 COVID 19 Vaccine. The rechallenge was not applicable, as the event happened after the first dose. The events were reported as resolved. The benefit-risk relationship of mRNA-1273 COVID 19 Vaccine, is not affected by this report.; Sender's Comments: This is a regulatory authority case concerning  a patient of unknown age and gender, with no relevant medical history, who experienced the unexpected non-serious events of Covid-19. The events occurred approximately on an unknown day after the first dose of mRNA-1273 COVID 19 Vaccine. The rechallenge was not applicable, as the event happened after the first dose. The events were reported as resolved. The benefit-risk relationship of mRNA-1273 COVID 19 Vaccine, is not affected by this report.
Patient's friend called office on 3/29/21 to notify PCP that patient had passed away on 3/26/21.
Patient has a red rash that is itching, painful, causing numbness in the injection site area. It looks and sounds like shingles.
RASH ON BOTH HANDS AND SORENESS AND INFLAMMATION OF ANKLES, KNEES, ELBOWS, AND WRISTS ON BOTH SIDES OF MY BODY
Deep seated arm pain since Td vaccine was administered. No ecchymosis or other traumatic signs. Follow up on 06/06/05: Patient does not have any restriction in range of motion he just has a constant pain in his arm.
Injection site pain, body aches, headache, dizziness, nausea, and tiredness. Injection site pain started immediately after vaccine given and continued until now (approx. 24 hours later) . Body aches, headache, dizziness, nausea, and tiredness started about 8 hours after injection and continued until now (approx. 24 hours later)
sore arm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 71-year-old female patient received bnt162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: LOSARTAN POTASSIUM, start date: 27Dec2022 (ongoing); RALOXIFENE (ongoing). The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "sore arm".  The information on the batch/lot number for bnt162b2 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300321150 same patient/drug, different dose/AE;
After receiving TD and Hep B, complained of headache and began crying (within about 1-2 minutes). Mother standing next to her and held and braced her, preventing her from falling. She lost consciousness and had eye's rolling back, flaccid jerking movements of extremities and incontinent of urine. Regained consciousness within 1 minute and complained of a headache, stomach ache and pain in left deltoid area.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 66-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 13Sep2022 as dose 4 (booster), single (Lot number: HH9702) at the age of 66 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Elevated cholesterol" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19.
Information has been received from a physician concerning a female (age unknown), who, on an unspecified date, was vaccinated intramuscularly with a dose of Gardasil.  Subsequently, almost immediately after receiving the vaccination the patient became very lightheaded.  The patient did not seek medical attention.  The patient recovered within five minutes after the vaccine was administered.  No product quality complaint was involved.  Additional information has been requested.
Follow-up information provided additional events, product details, lab results and patient demographics. This case was considered medically important. Information regarding Hib-Titer Vaccine was received from an attorney regarding an 18-month-old male patient who experienced PDD, autism, speech language delay, neurological damage and mercury poisoning. The patient received the fourth dose on 11-Oct-2000. The patient also received the fourth dose of DTaP (manufacturer unknown) on 11-Oct-2000. Medical records received from an attorney, alleged that on unspecified dates, the patient having received a dose of Hib, along with other childhood vaccines, experienced PDD in Jan-2001, autism in Feb-2001 and speech language delay in Oct--2001. The patient also experienced neurological damage and mercury poisoning. The patient's outcome was unknown. No additional information was available at the time of this report. Blood lead (results: 5 ug/dL) was done on 26-Dec-2000.
Felt prickly & hot from inside - out. 'I just want to itch it but I know I shouldn't'.  Site is at injcetion site; 3" x 2 3/4" raised, bright red, warm/hot to touch. Denies any other S/S. Reports placing Hydrocortizone Cr. on it.
4.5 INCH X 3 INCH area of erythema, warmth, and induration on left deltoid, pain with range of motion.  Diagnosis: cellulitis of upper arm. Prescribed Keflex suspension, 760mg daily by mouth for 7 days
Immunizations of 3-4-03: Child had high temp 103.8. Ax Within 12 hrs after imm. Temp came down to 100.4 Ax with Tylenol. Temp stayed for several days. Temp was normal by 3-10-04. Child "back to her normal self." Immunizations of 4-8-03: Temp high 102.4 Ax after c midnight after imm. high temp cont- at least 2 days. Mom "thinks" she saw doctor. Approx 1 1/2 weeks later, child developed developmental delays. Mom states that approx. 1 1/2 weeks after imm. (0f 4/8/03) were given, pt stopped talking, stopped lifting up her arms to be held, developed a flat expression previously she had been "very happy" "bubbly", was saying a few words (mama, dada, up) and would hold her hands up (to be held) and say "up". She stopped looking at parents when they called her name. Audiologist determined hearing was normal. Testing shows that she is functioning at a 9 month level with communication skills and speech is "severely delayed." Therapies are currently being set up with Learning Center. Parents are trying dietary changes to determine possible allergies (ie stopped milk and switched to Isomil formula). She has appointment with neurologist 6/7/04 for testing. Mom also states child has developed obsessive compulsive behaviors. Was diagnosed by Learning Center as being "severely developmentally delayed."
Information has been received from a 21 year old female who on 02/04/00 was vaccinated with the 1st dose of Hepatitis B vaccine recombinant. Concomitant therapy included a 1st dose of Varicella Virus Vaccine Live. On 02/04/00, the patient broke out in a sweat and almost passed out. She also "felt she may have a fever". No further information is available.
no additional AE details; vaccines were administered after experiencing temperature excursion.; This spontaneous report was received from a medical assistant and refers to a patient of unknown gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided.  On an unknown date, the varicella virus vaccine live (oka/merck) (VARIVAX) lot # T032317, expiration date 22-SEP-2022, experienced the temperature excursion of (6 degrees Fahrenheit (F) to 14 F) (8.5 F) for 0 hours 18 minutes and 0 seconds; 6 F to 14 F (11.9 F) for 1 hour 0 minutes. Cumulative timeframe: 1 hour and 18 minutes. On 04-OCT-2021, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck) (VARIVAX) lot # T032317 (formulation, concentration, exact dose, dose number, route of administration and anatomical location were not reported) for prophylaxis (product storage error). No additional adverse event details were provided. There were no previous excursions reported.
Pt. states 1 hour post vaccine she began to see "floaties" in (R) eye only. Lasted 2 hours, then resolved. No issues since then.
No adverse event or treatment for patient. Multidose vial experience excursion on the following days due to brief excursion related to inventory & stocking -  April 6, 2022  - 8 minutes at 8.1 C April 8, 2022 - 59 minutes at 9.6 C April 11, 2022 - 56 minutes at 9.1 C  Vaccine was administered on April 14, 2022 is the dose valid?
PT had an itching sensation in the back of the right arm. PT was rubbing the site and noticed a red rash like reaction going from the shot site which was administered intramuscularly. The area was approximately 10cm. The patent was given Typhoid in the same arm which was not near the red area of the anthrax shot. Patent was given 1 Capsule 50mg Diphehydromine. The rash cleared up then after.
When I got up in the morning, I felt a little funny. The dog and I go out to feed the birds, the bottom of my neck, top of my chest felt weird. I took my blood pressure it was unusual; I took it again and it was still unusual. I then took my pulse, when I noticed my pulse was very different than what it should be, I had my wife come and take it for me. She agreed that it was very irregular for me. We called the ambulance who came checked me out and took me to the emergency room. They ran a lot of tests, but I cannot remember what they were, they did identify I was in A-fib and started an IV with medication. I spent the night in the hospital with medication and no restrictions, with directions to follow up with my primary care physician and a cardiologist.
Initial case received from a physician on 12 July 2010. A 12-year-old patient received injections of ADACEL (lot number C3357AA) and MENACTRA (lot number reported as C3069AA; not a valid sanofi pasteur lot number) on 25 May 2010. Medical history and concomitant medications were not reported. Approximately 3 weeks post-vaccination, the patient began experiencing patches of alopecia. Symptoms later progressed to alopecia totalis. The patient was seen by a physician; testing and treatment were not reported. At the time of the report, the outcome was unknown. Follow-up information received from a health care professional on 16 September 2010 reported that the patient had no adverse events following prior vaccinations. The patient received the ADACEL, lot number C3357AA intramuscularly (IM) in the left deltoid and the MENACTRA, corrected lot number U3069AA (previously reported as C3069A) IM in the right deltoid. The patient was under the treatment by a dermatologist. The outcome remained unknown. Documents held by sender: None.